COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 9, Pages 1048
Publisher
MDPI AG
Online
2021-09-22
DOI
10.3390/vaccines9091048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
- (2021) Fulvia Pimpinelli et al. Journal of Hematology & Oncology
- COVID-19 and cancer: 1 year on
- (2021) The Lancet Oncology LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
- (2021) Aakash Desai et al. Nature Reviews Clinical Oncology
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Serological response to COVID-19 vaccination in patients with cancer older than 80 years
- (2021) Daniela Iacono et al. Journal of Geriatric Oncology
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
- (2020) Elisa Maria Stroppa et al. Future Oncology
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
- (2020) Masumi Ueda et al. Journal of the National Comprehensive Cancer Network
- Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)?
- (2020) Georgios Chamilos et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started